,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,1195,1,2,,48416644,4659569,Active,,,,,DSSTox (FDAMDD) FDA Maximum (Recommended) Daily Dose Database,Other,,
1,21849,7,1,,103412696,4659569,Unspecified,,,,,In vitro clearance in dog in 1000000 cells,Other,10602692.0,
2,21851,7,1,,103412696,4659569,Unspecified,,,,,In vitro clearance in human in 1000000 cells,Other,10602692.0,
3,21852,7,1,,103412696,4659569,Unspecified,,,,,In vitro clearance in rat in 1000000 cells,Other,10602692.0,
4,21853,6,2,,103412696,4659569,Unspecified,,,,,In vivo clearance in dog,Other,10602692.0,
5,21856,6,2,,103412696,4659569,Unspecified,,,,,In vivo clearance in human,Other,10602692.0,
6,21858,6,2,,103412696,4659569,Unspecified,,,,,In vivo clearance in rat,Other,10602692.0,
7,49912,3,6,,103412696,4659569,Unspecified,,,,,Inhibition of Catechol O-methyltransferase activity in SK-N-SH cells at a concentration of 100 nM,Other,11806720.0,
8,49922,7,1,,103412696,4659569,Active,,,0.0022,IC50,Inhibition of Catechol O-methyltransferase activity in rat brain,Confirmatory,11806720.0,
9,49923,6,3,,103412696,4659569,Unspecified,,,927.0,IC50,Inhibition of Catechol O-methyltransferase activity in rat liver,Confirmatory,11806720.0,
10,50078,3,7,,103412696,4659569,Unspecified,,,,,Percent inhibition of Catechol O-methyltransferase activity in rat brain at dose of 30 mg/kg determined at 0.5 hr after its administration,Other,11806720.0,
11,50079,3,7,,103412696,4659569,Unspecified,,,,,Percent inhibition of Catechol O-methyltransferase activity in rat brain at dose of 30 mg/kg determined at 1 hr after its administration,Other,11806720.0,
12,50080,3,7,,103412696,4659569,Unspecified,,,,,Percent inhibition of Catechol O-methyltransferase activity in rat brain at dose of 30 mg/kg determined at 3 hr after its administration,Other,11806720.0,
13,50082,3,7,,103412696,4659569,Unspecified,,,,,Percent inhibition of Catechol O-methyltransferase activity in rat brain at dose of 30 mg/kg determined at 9 hr after its administration,Other,11806720.0,
14,50083,3,7,,103412696,4659569,Unspecified,,,,,Percent inhibition of Catechol O-methyltransferase activity in rat liver at dose of 30 mg/kg determined at 0.5 hr after its administration,Other,11806720.0,
15,50084,3,7,,103412696,4659569,Unspecified,,,,,Percent inhibition of Catechol O-methyltransferase activity in rat liver at dose of 30 mg/kg determined at 1 hr after its administration,Other,11806720.0,
16,50085,3,7,,103412696,4659569,Unspecified,,,,,Percent inhibition of Catechol O-methyltransferase activity in rat liver at dose of 30 mg/kg determined at 3 hr after its administration,Other,11806720.0,
17,50086,3,7,,103412696,4659569,Unspecified,,,,,Percent inhibition of Catechol O-methyltransferase activity in rat liver at dose of 30 mg/kg determined at 6 hr after its administration,Other,11806720.0,
18,50088,3,7,,103412696,4659569,Unspecified,,,,,Percent inhibition of Catechol O-methyltransferase activity in rat liver at dose of 30 mg/kg determined at 9 hr after its administration,Other,11806720.0,
19,50093,3,7,,103412696,4659569,Unspecified,,,,,percent inhibition of Catechol O-methyltransferase activity in rat brain at dose of 30 mg/kg determined at 6 hr after its administration,Other,11806720.0,
20,256792,3,10,,103412696,4659569,Unspecified,116907.0,1312.0,,,Percentage inhibitory activity against COMT at 100 nM in human neuroblastoma SK-N-SH cells,Other,16335931.0,
21,256793,9,5,,103412696,4659569,Active,116909.0,24267.0,0.93,IC50,Inhibitory activity against COMT in rat liver,Confirmatory,16335931.0,
22,256794,9,5,,103412696,4659569,Active,116909.0,24267.0,2.2,IC50,Inhibitory activity against COMT in rat brain,Confirmatory,16335931.0,
23,256795,3,9,,103412696,4659569,Unspecified,116909.0,24267.0,,,Percentage inhibitory activity against COMT for 0.5h in homogenates of rat brain administered with 30mg/kg by Gastric tube,Other,16335931.0,
24,256796,4,7,,103412696,4659569,Unspecified,116909.0,24267.0,,,Percentage inhibitory activity against COMT for 1h in homogenates of rat brain administered with 30mg/kg by Gastric tube,Other,16335931.0,
25,256797,3,9,,103412696,4659569,Unspecified,116909.0,24267.0,,,Percentage inhibitory activity against COMT for 3h in homogenates of rat brain administered with 30mg/kg by Gastric tube,Other,16335931.0,
26,256798,4,7,,103412696,4659569,Unspecified,116909.0,24267.0,,,Percentage inhibitory activity against COMT for 6h in homogenates of rat brain administered with 30 mg/kg by Gastric tube,Other,16335931.0,
27,256799,3,9,,103412696,4659569,Unspecified,116909.0,24267.0,,,Percentage inhibitory activity against COMT for 9h in homogenates of rat brain administered with 30 mg/kg by Gastric tube,Other,16335931.0,
28,256800,3,9,,103412696,4659569,Unspecified,116909.0,24267.0,,,Percentage inhibitory activity against COMT for 1h in homogenates of rat liver administered with 30 mg/kg by Gastric tube,Other,16335931.0,
29,256801,3,9,,103412696,4659569,Unspecified,116909.0,24267.0,,,Percentage inhibitory activity against COMT for 6h in homogenates of rat liver administered with 30 mg/kg by Gastric tube,Other,16335931.0,
30,256802,3,9,,103412696,4659569,Unspecified,116909.0,24267.0,,,Percentage inhibitory activity against COMT for 0.5h in homogenates of rat liver administered with 30mg/kg by Gastric tube,Other,16335931.0,
31,256803,3,9,,103412696,4659569,Unspecified,116909.0,24267.0,,,Percentage inhibitory activity against COMT for 3h in homogenates of rat liver administered with 30 mg/kg by Gastric tube,Other,16335931.0,
32,256804,4,7,,103412696,4659569,Unspecified,116909.0,24267.0,,,Percentage inhibitory activity against COMT for 9h in homogenates of rat liver administered with 30mg/kg by Gastric tube,Other,16335931.0,
33,281569,4,10,,103412696,4659569,Unspecified,116907.0,1312.0,,,Inhibition of COMT in human SK-N-SH cells at 100 nM,Other,15566291.0,
34,281570,3,4,,103412696,4659569,Unspecified,,,,,"Inhibition of peripheral COMT in mouse liver at 30 mg/kg, po by gastric tube after 1 hr",Other,15566291.0,
35,281571,3,4,,103412696,4659569,Unspecified,,,,,"Inhibition of central COMT in mouse brain at 30 mg/kg, po by gastric tube after 1 hr",Other,15566291.0,
36,281572,3,4,,103412696,4659569,Unspecified,,,,,"Inhibition of peripheral COMT in mouse liver at 30 mg/kg, po by gastric tube after 6 hrs",Other,15566291.0,
37,281573,4,3,,103412696,4659569,Unspecified,,,,,"Inhibition of central COMT in mouse brain at 30 mg/kg, po by gastric tube after 6 hrs",Other,15566291.0,
38,425652,7,2,,103412696,4659569,Unspecified,,,,,Total body clearance in human,Other,19445515.0,
39,425653,7,2,,103412696,4659569,Unspecified,,,,,Renal clearance in human,Other,19445515.0,
40,473638,3,3,,103412696,4659569,Unspecified,,,,,"Inhibition of COMT in NMRI mouse liver homogenates assessed as metanephrine formation at 30 mg/kg, po measured after 6 hrs relative to control",Other,20334432.0,
41,473640,3,3,,103412696,4659569,Unspecified,,,,,"Inhibition of COMT in Wistar rat liver homogenates assessed as metanephrine formation at 3 mg/kg, po measured after 3 hrs relative to control",Other,20334432.0,
42,473641,3,3,,103412696,4659569,Unspecified,,,,,"Inhibition of COMT in NMRI mouse liver homogenates assessed as metanephrine formation at 3 mg/kg, po measured after 3 hrs relative to control",Other,20334432.0,
43,473642,3,4,,103412696,4659569,Unspecified,,,,,Cytotoxicity against mouse Neuro2a cells assessed as cell viability at 30 uM after 24 hrs,Other,20334432.0,
44,473643,6,2,,103412696,4659569,Unspecified,,,,,Inhibition of COMT in po dosed Wistar rat liver homogenates assessed as metanephrine formation measured up to 3 hrs relative to control,Other,20334432.0,
45,473644,4,3,,103412696,4659569,Active,,,,,"Inhibition of COMT in Wistar rat liver homogenates assessed as metanephrine formation at 3 mg/kg, po measured after 1 hr",Other,20334432.0,
46,473645,4,3,,103412696,4659569,Active,,,,,"Inhibition of COMT in Wistar rat brain homogenates assessed as metanephrine formation at 3 mg/kg, po measured after 1 hr",Other,20334432.0,
47,473646,4,3,,103412696,4659569,Active,,,,,"Inhibition of COMT in Wistar rat liver homogenates assessed as metanephrine formation at 3 mg/kg, po measured after 3 hrs",Other,20334432.0,
48,473647,4,3,,103412696,4659569,Active,,,,,"Inhibition of COMT in Wistar rat brain homogenates assessed as metanephrine formation at 3 mg/kg, po measured after 3 hrs",Other,20334432.0,
49,473648,4,3,,103412696,4659569,Inactive,,,,,"Inhibition of peripheral COMT in Wistar rat liver homogenates assessed as metanephrine formation at 3 mg/kg, po measured after 9 hrs",Other,20334432.0,
50,473649,4,3,,103412696,4659569,Inactive,,,,,"Inhibition of peripheral COMT in Wistar rat brain homogenates assessed as metanephrine formation at 3 mg/kg, po measured after 9 hrs",Other,20334432.0,
51,473650,3,3,,103412696,4659569,Unspecified,,,,,"Inhibition of central COMT in Wistar rat liver homogenates assessed as metanephrine formation at 3 mg/kg, po measured after 9 hrs",Other,20334432.0,
52,473651,3,3,,103412696,4659569,Unspecified,,,,,"Inhibition of central COMT in Wistar rat brain homogenates assessed as metanephrine formation at 3 mg/kg, po measured after 9 hrs",Other,20334432.0,
53,473656,3,4,,103412696,4659569,Unspecified,,,,,"Inhibition of COMT in Wistar rat plasma assessed as increase L-DOPA level at 3 mg/kg, po co-administered with L-dopa and benserazide measured after 2 hrs by HPLC analysis",Other,20334432.0,
54,473657,3,4,,103412696,4659569,Unspecified,,,,,"Inhibition of COMT in Wistar rat plasma assessed as increase L-DOPA level at 3 mg/kg, po co-administered with L-dopa and benserazide measured after 7 hrs by HPLC analysis",Other,20334432.0,
55,473658,4,3,,103412696,4659569,Inactive,,,,,"Inhibition of COMT in Wistar rat plasma assessed as increase L-DOPA level at 3 mg/kg, po co-administered with L-dopa and benserazide measured after 24 hrs by HPLC analysis",Other,20334432.0,
56,473659,4,3,,103412696,4659569,Active,,,,,"Inhibition of COMT in Wistar rat plasma assessed as decrease in 3-O-methyl-L-Dopa level at 3 mg/kg, po co-administered with L-dopa and benserazide measured after 2 hrs by HPLC analysis",Other,20334432.0,
57,473660,4,3,,103412696,4659569,Active,,,,,"Inhibition of COMT in Wistar rat plasma assessed as decrease in 3-O-methyl-L-Dopa level at 3 mg/kg, po co-administered with L-dopa and benserazide measured after 7 hrs by HPLC analysis",Other,20334432.0,
58,473661,4,3,,103412696,4659569,Active,,,,,"Inhibition of COMT in Wistar rat plasma assessed as decrease in 3-O-methyl-L-Dopa level at 3 mg/kg, po co-administered with L-dopa and benserazide measured after 24 hrs by HPLC analysis",Other,20334432.0,
59,539464,4,2,,103412696,4659569,Unspecified,,,,,Solubility of the compound in 0.1 M phosphate buffer at 600 uM at pH 7.4 after 24 hrs by LC/MS/MS analysis,Other,21055935.0,
60,539472,6,1,,103412696,4659569,Unspecified,,,,,Solubility of the compound at pH 7.4,Other,21055935.0,
61,540209,4,3,,103412696,4659569,Unspecified,,,,,Volume of distribution at steady state in human after iv administration,Other,18426954.0,
62,540210,4,3,,103412696,4659569,Unspecified,,,,,Clearance in human after iv administration,Other,18426954.0,
63,540211,2,5,,103412696,4659569,Unspecified,,,,,Fraction unbound in human after iv administration,Other,18426954.0,
64,540212,4,3,,103412696,4659569,Unspecified,,,,,Mean residence time in human after iv administration,Other,18426954.0,
65,540213,4,3,,103412696,4659569,Unspecified,,,,,Half life in human after iv administration,Other,18426954.0,
66,588209,2,3,,103412696,4659569,Unspecified,,,,,Literature-mined public compounds from Greene et al multi-species hepatotoxicity modelling dataset,Other,20553011.0,
67,588210,2,4,,103412696,4659569,Unspecified,,,,,Human drug-induced liver injury (DILI) modelling dataset from Ekins et al,Other,20843939.0,
68,588211,2,3,,103412696,4659569,Unspecified,,,,,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans",Other,20014752.0,
69,588212,2,3,,103412696,4659569,Unspecified,,,,,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents",Other,20014752.0,
70,588213,2,3,,103412696,4659569,Unspecified,,,,,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents",Other,20014752.0,
71,588220,2,3,,103412696,4659569,Unspecified,,,,,Literature-mined public compounds from Kruhlak et al phospholipidosis modelling dataset,Other,20020916.0,
72,589080,1,10,,103412696,4659569,Unspecified,332278237.0,7366.0,,,Substrate of human UDP-glucuronosyltransferase UGT2B15,Other,,
73,602332,1,1,,50126317,4659569,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
74,624030,1,2,,50126317,4659569,Inconclusive,160794.0,,32.1968,Potency,Biochemical firefly luciferase enzyme assay for NPC,Confirmatory,,
75,624170,1,1,,50126317,4659569,Inactive,71051501.0,2744.0,,Potency,qHTS for Inhibitors of Glutaminase (GLS),Confirmatory,,
76,624172,1,1,,50126317,4659569,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists,Confirmatory,,
77,624173,1,3,,50126317,4659569,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors,Confirmatory,,
78,624349,1,2,,92308890,4659569,Inactive,,,,,A screen for compounds that inhibit liver stage malaria,Other,,
79,624637,3,7,,103412696,4659569,Unspecified,29839451.0,54600.0,66.0,Km,Drug glucuronidation reaction catalyzed by human recombinant UGT1A9,Confirmatory,15781124.0,
80,624638,3,7,,103412696,4659569,Unspecified,332278237.0,7366.0,429.0,Km,Drug glucuronidation reaction catalyzed by human recombinant UGT2B15,Confirmatory,15781124.0,
81,625276,1,3,,103412696,4659569,Unspecified,,,,,FDA Liver Toxicity Knowledge Base Benchmark Dataset (LTKB-BD) drugs of most concern for DILI,Other,21624500.0,
82,625279,1,3,,103412696,4659569,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for bilirubinemia,Other,22194678.0,
83,625280,1,3,,103412696,4659569,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholecystitis,Other,22194678.0,
84,625281,1,3,,103412696,4659569,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholelithiasis,Other,22194678.0,
85,625282,1,3,,103412696,4659569,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cirrhosis,Other,22194678.0,
86,625283,1,3,,103412696,4659569,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for elevated liver function tests,Other,22194678.0,
87,625284,1,3,,103412696,4659569,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic failure,Other,22194678.0,
88,625285,1,3,,103412696,4659569,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic necrosis,Other,22194678.0,
89,625286,1,3,,103412696,4659569,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatitis,Other,22194678.0,
90,625287,1,3,,103412696,4659569,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatomegaly,Other,22194678.0,
91,625288,1,3,,103412696,4659569,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for jaundice,Other,22194678.0,
92,625289,1,3,,103412696,4659569,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver disease,Other,22194678.0,
93,625290,1,3,,103412696,4659569,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver fatty,Other,22194678.0,
94,625291,1,3,,103412696,4659569,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver function tests abnormal,Other,22194678.0,
95,625292,1,3,,103412696,4659569,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) combined score,Other,22194678.0,
96,651631,4,1,,144206516,4659569,Inconclusive,269849759.0,7157.0,29.8493,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
97,651631,4,1,,144212731,4659569,Inconclusive,269849759.0,7157.0,24.3365,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
98,651632,4,1,,144206516,4659569,Inactive,296439460.0,79915.0,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
99,651632,4,1,,144212731,4659569,Inactive,296439460.0,79915.0,17.2289,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
100,651633,4,1,,144206516,4659569,Active,,,23.7101,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
101,651633,4,1,,144212731,4659569,Active,,,54.4827,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
102,651634,4,1,,144206516,4659569,Inconclusive,,,23.7101,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
103,651634,4,1,,144212731,4659569,Active,,,30.6379,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
104,651828,1,2,,92308890,4659569,Inactive,127925.0,,,,A screen for compounds that inhibit nucleocapsid/RNA interactions in Rift Valley Fever Virus,Other,,
105,652048,1,2,,144206516,4659569,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Agonist: qHTS,Screening,,
106,652051,1,1,,144206516,4659569,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Potentiators: qHTS,Screening,,
107,686978,1,1,,144206516,4659569,Inconclusive,79154014.0,55775.0,29.8554,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
108,686979,1,1,,144206516,4659569,Inconclusive,79154014.0,55775.0,33.4983,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
109,720516,2,1,,144206516,4659569,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
110,720516,2,1,,144212731,4659569,Inconclusive,296439460.0,79915.0,20.8733,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
111,720532,1,1,,144206516,4659569,Inactive,420597.0,,,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
112,720533,1,1,,144206516,4659569,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
113,720552,2,1,,144206516,4659569,Inactive,269849759.0,7157.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
114,720552,2,1,,144212731,4659569,Inconclusive,269849759.0,7157.0,66.0073,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
115,720634,2,1,,144206516,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
116,720634,2,1,,144212731,4659569,Inconclusive,,,27.305999999999997,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
117,720635,2,1,,144206516,4659569,Active,,,26.6032,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
118,720635,2,1,,144212731,4659569,Active,,,4.8558,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
119,720637,2,1,,144206516,4659569,Active,,,27.644000000000002,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
120,720637,2,1,,144212731,4659569,Inconclusive,,,5.66142,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
121,720641,1,2,,92308890,4659569,Inactive,15923709.0,,,,A screen for compounds that inhibit the activity of LtaS in Staphylococcus aureus,Other,,
122,720674,2,2,,144206516,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
123,720674,2,2,,144212731,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
124,720675,2,2,,144206516,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
125,720675,2,2,,144212731,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
126,720678,2,1,,144206516,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
127,720678,2,1,,144212731,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
128,720679,2,1,,144206516,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
129,720679,2,1,,144212731,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
130,720680,2,1,,144206516,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
131,720680,2,1,,144212731,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
132,720681,2,1,,144206516,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
133,720681,2,1,,144212731,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
134,720682,2,1,,144206516,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
135,720682,2,1,,144212731,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
136,720683,2,1,,144206516,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
137,720683,2,1,,144212731,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
138,720684,2,1,,144206516,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
139,720684,2,1,,144212731,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
140,720685,2,1,,144206516,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
141,720685,2,1,,144212731,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
142,720686,2,1,,144206516,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
143,720686,2,1,,144212731,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
144,720687,2,2,,144206516,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
145,720687,2,2,,144212731,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
146,720691,4,1,,144206516,4659569,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
147,720691,4,1,,144212731,4659569,Inconclusive,311348376.0,2908.0,61.6448,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
148,720692,3,1,,144206516,4659569,Inconclusive,311348376.0,2908.0,21.3138,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
149,720692,3,1,,144212731,4659569,Active,311348376.0,2908.0,34.6654,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
150,720693,3,1,,144206516,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
151,720693,3,1,,144212731,4659569,Active,,,48.9662,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
152,720717,1,3,,92308890,4659569,Inactive,1718329.0,,,,Chemical Probes of Kaposi's Sarcoma Herpes Virus Latent Infection,Other,,
153,720719,2,1,,144206516,4659569,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
154,720719,2,1,,144212731,4659569,Inconclusive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
155,720725,2,1,,144206516,4659569,Active,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
156,720725,2,1,,144212731,4659569,Inconclusive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
157,743012,3,1,,144206516,4659569,Inconclusive,,,33.4915,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
158,743012,3,1,,144212731,4659569,Inconclusive,,,68.5896,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
159,743014,3,1,,144206516,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
160,743014,3,1,,144212731,4659569,Active,,,68.5896,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
161,743015,3,1,,144206516,4659569,Inconclusive,,,33.4915,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
162,743015,3,1,,144212731,4659569,Active,,,48.5577,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
163,743033,3,1,,144206516,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
164,743033,3,1,,144212731,4659569,Inconclusive,,,43.6412,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
165,743035,2,1,,144206516,4659569,Inconclusive,124375976.0,367.0,26.8325,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
166,743035,2,1,,144212731,4659569,Inconclusive,124375976.0,367.0,13.8006,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
167,743036,2,1,,144206516,4659569,Inconclusive,124375976.0,367.0,13.4481,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
168,743036,2,1,,144212731,4659569,Inconclusive,124375976.0,367.0,12.2998,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
169,743040,3,1,,144206516,4659569,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
170,743040,3,1,,144212731,4659569,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
171,743041,3,1,,144206516,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
172,743041,3,1,,144212731,4659569,Inconclusive,,,68.5896,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
173,743042,3,1,,144206516,4659569,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
174,743042,3,1,,144212731,4659569,Inconclusive,124375976.0,367.0,68.5896,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
175,743053,2,1,,144206516,4659569,Inconclusive,124375976.0,367.0,11.3152,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
176,743053,2,1,,144212731,4659569,Inconclusive,124375976.0,367.0,8.06424,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
177,743054,2,1,,144206516,4659569,Inactive,124375976.0,367.0,,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
178,743054,2,1,,144212731,4659569,Inconclusive,124375976.0,367.0,61.1306,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
179,743063,2,1,,144206516,4659569,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
180,743063,2,1,,144212731,4659569,Inconclusive,124375976.0,367.0,27.5357,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
181,743064,3,1,,144206516,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
182,743064,3,1,,144212731,4659569,Active,,,61.1306,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
183,743065,3,1,,144206516,4659569,Inconclusive,399498506.0,24831.0,33.4915,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
184,743065,3,1,,144212731,4659569,Active,399498506.0,24831.0,68.5896,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
185,743066,3,1,,144206516,4659569,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
186,743066,3,1,,144212731,4659569,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
187,743067,2,1,,144206516,4659569,Inconclusive,399498506.0,24831.0,29.8493,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
188,743067,2,1,,144212731,4659569,Inconclusive,399498506.0,24831.0,61.1306,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
189,743069,2,1,,144206516,4659569,Inconclusive,348019627.0,2099.0,13.4481,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
190,743069,2,1,,144212731,4659569,Inconclusive,348019627.0,2099.0,10.9622,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
191,743074,2,1,,144206516,4659569,Inconclusive,,,23.9145,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
192,743074,2,1,,144212731,4659569,Inconclusive,,,19.4938,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
193,743075,2,1,,144206516,4659569,Inactive,348019627.0,2099.0,6.74,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
194,743075,2,1,,144212731,4659569,Inactive,348019627.0,2099.0,4.8966,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
195,743077,2,1,,144206516,4659569,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
196,743077,2,1,,144212731,4659569,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
197,743078,2,1,,144206516,4659569,Inconclusive,348019627.0,2099.0,23.0141,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
198,743078,2,1,,144212731,4659569,Inconclusive,348019627.0,2099.0,32.1043,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
199,743079,3,1,,144206516,4659569,Inactive,348019627.0,2099.0,33.4915,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
200,743079,3,1,,144212731,4659569,Inconclusive,348019627.0,2099.0,54.4827,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
201,743080,3,1,,144206516,4659569,Inconclusive,348019627.0,2099.0,33.4915,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
202,743080,3,1,,144212731,4659569,Inconclusive,348019627.0,2099.0,68.5896,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
203,743081,3,1,,144206516,4659569,Active,,,33.4915,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
204,743081,3,1,,144212731,4659569,Active,,,54.4827,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
205,743083,3,1,,144206516,4659569,Inconclusive,119597822.0,1588.0,29.8493,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
206,743083,3,1,,144212731,4659569,Inconclusive,119597822.0,1588.0,68.5896,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
207,743084,3,1,,144206516,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
208,743084,3,1,,144212731,4659569,Inconclusive,,,68.5896,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
209,743085,3,1,,144206516,4659569,Inconclusive,51095037.0,196.0,14.9601,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
210,743085,3,1,,144212731,4659569,Inactive,51095037.0,196.0,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
211,743086,3,1,,144206516,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
212,743086,3,1,,144212731,4659569,Inconclusive,,,61.1306,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
213,743091,2,1,,144206516,4659569,Inconclusive,348019627.0,2099.0,33.4915,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
214,743091,2,1,,144212731,4659569,Inconclusive,348019627.0,2099.0,68.5896,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
215,743094,3,1,,144206516,4659569,Inconclusive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
216,743094,3,1,,144212731,4659569,Inconclusive,216409692.0,5468.0,3.4665,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
217,743122,2,1,,144206516,4659569,Inconclusive,51095037.0,196.0,,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
218,743122,2,1,,144212731,4659569,Inconclusive,51095037.0,196.0,,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
219,743139,2,1,,144206516,4659569,Inactive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
220,743139,2,1,,144212731,4659569,Inconclusive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
221,743140,2,1,,144206516,4659569,Inconclusive,216409692.0,5468.0,18.9959,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
222,743140,2,1,,144212731,4659569,Inconclusive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
223,743191,3,1,,144212731,4659569,Inconclusive,216409692.0,5468.0,30.8956,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
224,743191,3,1,,170465081,4659569,Inconclusive,216409692.0,5468.0,13.3322,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
225,743194,3,1,,144212731,4659569,Active,,,19.4938,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
226,743194,3,1,,170465081,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
227,743199,2,1,,144212731,4659569,Inconclusive,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
228,743199,2,1,,170465081,4659569,Inconclusive,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
229,743202,4,1,,144212731,4659569,Inconclusive,20149576.0,4780.0,68.5896,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
230,743202,4,1,,170465081,4659569,Inconclusive,20149576.0,4780.0,0.266,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
231,743203,3,1,,144212731,4659569,Active,,,9.6885,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
232,743203,3,1,,170465081,4659569,Inconclusive,,,4.216,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
233,743209,3,1,,144212731,4659569,Inconclusive,,,30.8956,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
234,743209,3,1,,170465081,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
235,743210,4,1,,144212731,4659569,Inactive,4504517.0,3315.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
236,743210,4,1,,170465081,4659569,Inactive,4504517.0,3315.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
237,743211,3,1,,144212731,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
238,743211,3,1,,170465081,4659569,Inconclusive,,,21.13,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
239,743212,3,1,,144212731,4659569,Inconclusive,216409690.0,5467.0,5.4941,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
240,743212,3,1,,170465081,4659569,Inconclusive,216409690.0,5467.0,4.216,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
241,743213,3,1,,144212731,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
242,743213,3,1,,170465081,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
243,743215,3,1,,144212731,4659569,Inconclusive,216409690.0,5467.0,27.5357,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
244,743215,3,1,,170465081,4659569,Inconclusive,216409690.0,5467.0,5.3076,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
245,743217,3,1,,144212731,4659569,Inconclusive,325495553.0,9971.0,19.4938,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
246,743217,3,1,,170465081,4659569,Inconclusive,325495553.0,9971.0,26.6011,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
247,743218,3,1,,144212731,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
248,743218,3,1,,170465081,4659569,Inconclusive,,,7.4972,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
249,743219,3,1,,144212731,4659569,Inconclusive,20149576.0,4780.0,7.695880000000001,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
250,743219,3,1,,170465081,4659569,Inconclusive,20149576.0,4780.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
251,743220,3,1,,144212731,4659569,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
252,743220,3,1,,170465081,4659569,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
253,743221,3,1,,144212731,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
254,743221,3,1,,170465081,4659569,Inconclusive,,,13.3322,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
255,743222,3,1,,144212731,4659569,Inconclusive,216409708.0,7421.0,1.3801,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
256,743222,3,1,,170465081,4659569,Inconclusive,216409708.0,7421.0,2.3708,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
257,743223,3,1,,144212731,4659569,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
258,743223,3,1,,170465081,4659569,Inconclusive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
259,743224,3,1,,144212731,4659569,Inconclusive,,,15.4845,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
260,743224,3,1,,170465081,4659569,Inconclusive,,,6.6819,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
261,743225,3,1,,144212731,4659569,Inconclusive,,,43.6412,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
262,743225,3,1,,170465081,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
263,743226,2,1,,144212731,4659569,Inconclusive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
264,743226,2,1,,170465081,4659569,Inconclusive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
265,743227,2,1,,144212731,4659569,Inconclusive,216409690.0,5467.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
266,743227,2,1,,170465081,4659569,Inconclusive,216409690.0,5467.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
267,743228,3,1,,144212731,4659569,Inactive,4504517.0,3315.0,,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
268,743228,3,1,,170465081,4659569,Inactive,4504517.0,3315.0,,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
269,743239,2,1,,144212731,4659569,Inactive,325495553.0,9971.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
270,743239,2,1,,170465081,4659569,Inactive,325495553.0,9971.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
271,743240,2,1,,144212731,4659569,Active,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
272,743240,2,1,,170465081,4659569,Inconclusive,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
273,743241,2,1,,144212731,4659569,Inconclusive,216409708.0,7421.0,3.8895199999999996,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
274,743241,2,1,,170465081,4659569,Inconclusive,216409708.0,7421.0,3.75751,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
275,743242,2,1,,144212731,4659569,Inactive,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
276,743242,2,1,,170465081,4659569,Inactive,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
277,743244,1,1,,144206516,4659569,Inactive,,,,Potency,qHTS Assay for Identifying Gametocytocidal Compounds,Confirmatory,,
278,743344,1,1,,50126317,4659569,Inactive,,,0.0007,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (3D7) proliferation,Confirmatory,,
279,743345,1,1,,50126317,4659569,Inactive,,,0.0042,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (DD2) proliferation,Confirmatory,,
280,743346,1,1,,50126317,4659569,Inactive,,,0.0012,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (DD2) proliferation (Rep 2),Confirmatory,,
281,743347,1,1,,50126317,4659569,Inactive,,,0.0006,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (HB3) proliferation,Confirmatory,,
282,977608,3,1,,208012531,4659569,Active,,,0.0022,IC50,Experimentally measured binding affinity data (IC50) for protein-ligand complexes derived from PDB,Other,11806720.0,
283,1079931,1,1,,103412696,4659569,Unspecified,,,,,"Moderate liver toxicity, defined via clinical-chemistry results: ALT or AST serum activity 6 times the normal upper limit (N) or alkaline phosphatase serum activity of 1.7 N. Value is number of references indexed. [column 'BIOL' in source]",Other,15646539.0,
284,1079932,1,1,,103412696,4659569,Unspecified,,,,,"Highest frequency of moderate liver toxicity observed during clinical trials, expressed as a percentage. [column '% BIOL' in source]",Other,15646539.0,
285,1079933,1,1,,103412696,4659569,Unspecified,,,,,"Acute liver toxicity defined via clinical observations and clear clinical-chemistry results: serum ALT or AST activity > 6 N or serum alkaline phosphatases activity > 1.7 N. This category includes cytolytic, choleostatic and mixed liver toxicity. Value is number of references indexed. [column 'AIGUE' in source]",Other,15646539.0,
286,1079934,1,1,,103412696,4659569,Unspecified,,,,,"Highest frequency of acute liver toxicity observed during clinical trials, expressed as a percentage. [column '% AIGUE' in source]",Other,15646539.0,
287,1079935,1,1,,103412696,4659569,Unspecified,,,,,"Cytolytic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is > 5 (see ACUTE). Value is number of references indexed. [column 'CYTOL' in source]",Other,15646539.0,
288,1079936,1,1,,103412696,4659569,Unspecified,,,,,"Choleostatic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is < 2 (see ACUTE). Value is number of references indexed. [column 'CHOLE' in source]",Other,15646539.0,
289,1079937,1,1,,103412696,4659569,Unspecified,,,,,"Severe hepatitis, defined as possibly life-threatening liver failure or through clinical observations. Value is number of references indexed. [column 'MASS' in source]",Other,15646539.0,
290,1079938,1,1,,103412696,4659569,Unspecified,,,,,"Chronic liver disease either proven histopathologically, or through a chonic elevation of serum amino-transferase activity after 6 months. Value is number of references indexed. [column 'CHRON' in source]",Other,15646539.0,
291,1079939,1,1,,103412696,4659569,Unspecified,,,,,"Cirrhosis, proven histopathologically. Value is number of references indexed. [column 'CIRRH' in source]",Other,15646539.0,
292,1079940,1,1,,103412696,4659569,Unspecified,,,,,"Granulomatous liver disease, proven histopathologically. Value is number of references indexed. [column 'GRAN' in source]",Other,15646539.0,
293,1079941,1,1,,103412696,4659569,Unspecified,,,,,"Liver damage due to vascular disease: peliosis hepatitis, hepatic veno-occlusive disease, Budd-Chiari syndrome. Value is number of references indexed. [column 'VASC' in source]",Other,15646539.0,
294,1079942,1,1,,103412696,4659569,Unspecified,,,,,"Steatosis, proven histopathologically. Value is number of references indexed. [column 'STEAT' in source]",Other,15646539.0,
295,1079943,1,1,,103412696,4659569,Unspecified,,,,,"Malignant tumor, proven histopathologically. Value is number of references indexed. [column 'T.MAL' in source]",Other,15646539.0,
296,1079944,1,1,,103412696,4659569,Unspecified,,,,,"Benign tumor, proven histopathologically. Value is number of references indexed. [column 'T.BEN' in source]",Other,15646539.0,
297,1079945,1,1,,103412696,4659569,Unspecified,,,,,Animal toxicity known. [column 'TOXIC' in source],Other,15646539.0,
298,1079946,1,1,,103412696,4659569,Unspecified,,,,,Presence of at least one case with successful reintroduction. [column 'REINT' in source],Other,15646539.0,
299,1079947,1,1,,103412696,4659569,Unspecified,,,,,Comments (NB not yet translated). [column 'COMMENTAIRES' in source],Other,15646539.0,
300,1079948,1,1,,103412696,4659569,Unspecified,,,,,"Times to onset, minimal and maximal, observed in the indexed observations. [column 'DELAI' in source]",Other,15646539.0,
301,1079949,1,1,,103412696,4659569,Unspecified,,,,,Proposed mechanism(s) of liver damage. [column 'MEC' in source],Other,15646539.0,
302,1117298,1,2,,170465081,4659569,Inactive,,,25.1189,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 green channel",Confirmatory,,
303,1117301,1,2,,170465081,4659569,Inactive,,,3.1623,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 1 blue channel",Confirmatory,,
304,1117302,1,2,,170465081,4659569,Inactive,,,5.6234,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen1 green channel",Confirmatory,,
305,1117303,1,2,,170465081,4659569,Inactive,,,5.02,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 1 ratio channel",Confirmatory,,
306,1117304,1,2,,170465081,4659569,Inactive,,,8.9125,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 blue channel",Confirmatory,,
307,1117305,1,2,,170465081,4659569,Inactive,,,8.9125,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 ratio channel",Confirmatory,,
308,1117310,1,1,,170465081,4659569,Inactive,,,25.1189,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, green channel",Confirmatory,,
309,1117311,1,1,,170465081,4659569,Inactive,,,3.16228,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen1, blue channel",Confirmatory,,
310,1117312,1,1,,170465081,4659569,Inactive,,,8.912510000000001,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen2, ratio channel",Confirmatory,,
311,1117314,1,1,,170465081,4659569,Inactive,,,8.912510000000001,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, blue channel",Confirmatory,,
312,1117315,1,1,,170465081,4659569,Inactive,,,5.62341,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen1, green channel",Confirmatory,,
313,1117318,1,1,,170465081,4659569,Inactive,,,5.01187,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen1, ratio channel",Confirmatory,,
314,1117322,1,1,,170465081,4659569,Active,,,1.87569,IC50,RKO viability from Cell TiterGlo-IC50,Confirmatory,,
315,1117323,1,1,,170465081,4659569,Active,,,4.53621,IC50,SNU-C1 viability from Cell TiterGlo-IC50,Confirmatory,,
316,1117326,1,1,,170465081,4659569,Inactive,,,,,nuclear beta catenin stimulation in WNT3A conditioned C2C12 cells-screen,Screening,,
317,1117329,1,1,,170465081,4659569,Inactive,,,,,insulin secretion from INS-1E cells in the presence of 5 mM glucose-screen,Screening,,
318,1117330,1,1,,170465081,4659569,Inactive,,,20.0,IC50,HT-29 viability from Cell TiterGlo-IC50,Confirmatory,,
319,1117332,1,1,,170465081,4659569,Active,,,2.29213,IC50,HCT116 viability from Cell TiterGlo-IC50,Confirmatory,,
320,1117334,1,1,,170465081,4659569,Active,,,2.50267,IC50,Colo320 viability from Cell TiterGlo-IC50,Confirmatory,,
321,1117336,1,1,,170465081,4659569,Active,,,,,GSK3B-pretreated HCT116 viability from Cell TiterGlo-screen,Screening,,
322,1117338,1,1,,170465081,4659569,Active,,,4.64385,IC50,SW480 viability from Cell TiterGlo-IC50,Confirmatory,,
323,1117339,1,1,,170465081,4659569,Active,,,0.26497,IC50,GSK3B-pretreated HCT116 viability from Cell TiterGlo-IC50,Confirmatory,,
324,1117340,1,1,,170465081,4659569,Inactive,,,,,VEGF stimulated ADSC/ECFC co-culture CD31-stained tube area decrease-screen,Screening,,
325,1117341,1,1,,170465081,4659569,Inactive,,,,,GLP1 secretion from NCI-H716 cells-screen,Screening,,
326,1117342,1,1,,170465081,4659569,Active,,,,,HCT116 viability from Cell TiterGlo-screen,Screening,,
327,1117343,1,1,,170465081,4659569,Active,,,,,SW480 viability from Cell TiterGlo-screen,Screening,,
328,1117346,1,1,,170465081,4659569,Active,,,,,DLD-1 viability from Cell TiterGlo-screen,Screening,,
329,1117352,1,1,,170465081,4659569,Inactive,,,6.14215,IC50,DLD-1 viability from Cell TiterGlo-IC50,Confirmatory,,
330,1159387,1,2,,103412696,4659569,Unspecified,,,,,"ASTRAZENECA: Octan-1-ol/water (pH7.4) distribution coefficent measured  by a shake flask method described in J. Biomol. Screen. 2011, 16, 348-355. Experimental range -1.5 to 4.5",Other,,
331,1159509,1,1,,144212731,4659569,Inactive,119626539.0,4790.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
332,1159509,1,1,,170465081,4659569,Inactive,119626539.0,4790.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
333,1159515,1,1,,144212731,4659569,Inconclusive,,,43.6412,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
334,1159515,1,1,,170465081,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
335,1159516,1,1,,144212731,4659569,Inactive,119611100.0,22926.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
336,1159516,1,1,,170465081,4659569,Inconclusive,119611100.0,22926.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
337,1159517,1,1,,144212731,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
338,1159517,1,1,,170465081,4659569,Inconclusive,,,23.9145,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
339,1159518,1,1,,144212731,4659569,Inactive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
340,1159518,1,1,,170465081,4659569,Inactive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
341,1159519,1,1,,144212731,4659569,Inconclusive,119611100.0,22926.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
342,1159519,1,1,,170465081,4659569,Inconclusive,119611100.0,22926.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
343,1159520,1,1,,144212731,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
344,1159520,1,1,,170465081,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
345,1159521,1,1,,144212731,4659569,Active,15928672.0,19885.0,27.305999999999997,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
346,1159521,1,1,,170465081,4659569,Active,15928672.0,19885.0,26.6032,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
347,1159523,1,1,,144212731,4659569,Active,15928672.0,19885.0,24.3365,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
348,1159523,1,1,,170465081,4659569,Active,15928672.0,19885.0,25.1151,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
349,1159525,1,1,,144212731,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
350,1159525,1,1,,170465081,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
351,1159526,1,1,,144212731,4659569,Inactive,119627033.0,3725.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
352,1159526,1,1,,170465081,4659569,Inactive,119627033.0,3725.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
353,1159527,1,1,,144212731,4659569,Inconclusive,325495497.0,6256.0,9.77,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
354,1159527,1,1,,170465081,4659569,Inconclusive,325495497.0,6256.0,9.5205,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
355,1159528,1,1,,144212731,4659569,Inactive,119627033.0,3725.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
356,1159528,1,1,,170465081,4659569,Inactive,119627033.0,3725.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
357,1159529,1,1,,144212731,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
358,1159529,1,1,,170465081,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
359,1159531,1,1,,144212731,4659569,Inconclusive,325495497.0,6256.0,21.8724,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
360,1159531,1,1,,170465081,4659569,Inactive,325495497.0,6256.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
361,1159551,1,1,,144212731,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
362,1159551,1,1,,170465081,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
363,1159552,1,1,,144212731,4659569,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
364,1159552,1,1,,170465081,4659569,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
365,1159553,2,1,,144212731,4659569,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
366,1159553,2,1,,170465081,4659569,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
367,1159555,1,1,,144212731,4659569,Inactive,325495463.0,5914.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
368,1159555,1,1,,170465081,4659569,Inactive,325495463.0,5914.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
369,1159614,1,2,,170465081,4659569,Inactive,22328079.0,2581.0,,Potency,A Novel Cell-Based Assay to Identify Small Molecules for B -Galactocerebrosidase,Confirmatory,,
370,1159620,1,1,,103412696,4659569,Active,,,,,Summary of drug indications.,Other,,
371,1159939,1,2,,103412696,4659569,Unspecified,68068087.0,2859.0,,EC50,Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis,Confirmatory,,
372,1159946,1,2,,103412696,4659569,Active,68068087.0,2859.0,,,Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution at 16 uM after 50 mins by resonant waveguide grating biosensor analysis in presence of GPR35 antagonist ML-145,Other,,
373,1159950,1,2,,103412696,4659569,Active,68068087.0,2859.0,49.2,EC50,Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay,Confirmatory,,
374,1159951,1,2,,103412696,4659569,Unspecified,68068087.0,2859.0,,,Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis relative to control,Other,,
375,1159952,1,2,,103412696,4659569,Unspecified,68068087.0,2859.0,,,Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay relative to zaprinast,Other,,
376,1196811,1,2,,103412696,4659569,Unspecified,11387050.0,7071.0,,,Inhibition of human KLF10 expressed in human HeLa cells assessed as reduction in transcriptional activity at 100 uM after 24 hrs by CACCC-responsive promoter driven TK-luciferase reporter gene assay,Other,25581017.0,
377,1196812,1,2,,103412696,4659569,Unspecified,11387050.0,7071.0,50.0,IC50,Inhibition of human KLF10 expressed in human HeLa cells assessed as reduction in transcriptional activity after 24 hrs by CACCC-responsive promoter driven TK-luciferase reporter gene assay,Confirmatory,25581017.0,
378,1209455,1,2,,103412696,4659569,Unspecified,262527527.0,8647.0,119.6,IC50,Inhibition of human BSEP expressed in plasma membrane vesicles of Sf21 cells assessed as inhibition of ATP-dependent [3H]taurocholate uptake,Confirmatory,21965623.0,
379,1209456,1,2,,103412696,4659569,Active,12585136.0,83569.0,47.2,IC50,Inhibition of Sprague-Dawley rat Bsep expressed in plasma membrane vesicles of Sf21 cells assessed as inhibition of ATP-dependent [3H]taurocholate uptake,Confirmatory,21965623.0,
380,1209457,1,1,,103412696,4659569,Active,,,,,Unbound Cmax in human plasma,Other,21965623.0,
381,1220237,1,1,,103412696,4659569,Unspecified,,,,,Unbound fraction during UGT-mediated glucuronidation in human intestinal microsomes,Other,22685216.0,
382,1220238,1,1,,103412696,4659569,Unspecified,,,,,Intrinsic clearance in human intestinal microsomes assessed UGT-mediated glucuronidation clearance,Other,22685216.0,
383,1220239,1,1,,103412696,4659569,Unspecified,,,,,Unbound intrinsic clearance in human intestinal microsomes assessed UGT-mediated glucuronidation clearance,Other,22685216.0,
384,1220240,1,1,,103412696,4659569,Inconclusive,,,,,Unbound fraction during CYP4500-mediated metabolism in human intestinal microsomes,Other,22685216.0,
385,1220241,1,1,,103412696,4659569,Unspecified,,,,,Intrinsic clearance in human intestinal microsomes assessed CYP450-mediated glucuronidation clearance,Other,22685216.0,
386,1220242,1,1,,103412696,4659569,Unspecified,,,,,Unbound intrinsic clearance in human intestinal microsomes assessed CYP450-mediated glucuronidation clearance,Other,22685216.0,
387,1220248,1,2,,103412696,4659569,Unspecified,29839451.0,54600.0,,,Activity of human UGT1A9 expressed in insect cells assessed as reduction in compound level after 30 mins,Other,22685216.0,
388,1220255,1,1,,103412696,4659569,Unspecified,,,,,Apparent permeability by PAMPA method,Other,22685216.0,
389,1220256,1,1,,103412696,4659569,Unspecified,,,,,Total clearance in human,Other,22685216.0,
390,1220257,1,2,,103412696,4659569,Unspecified,,,,,Ratio of drug level in blood to plasma in human,Other,22685216.0,
391,1220258,1,1,,103412696,4659569,Unspecified,,,,,Renal clearance in human,Other,22685216.0,
392,1220259,1,1,,103412696,4659569,Unspecified,,,,,Oral absorption in human,Other,22685216.0,
393,1220554,1,2,,103412696,4659569,Unspecified,,,,,Fraction unbound in Wistar Han rat brain homogenates at 1 uM after 6 hrs by equilibrium dialysis method,Other,21474681.0,
394,1220555,1,2,,103412696,4659569,Unspecified,,,,,Fraction unbound in Sprague-Dawley rat brain homogenates at 1 uM after 6 hrs by equilibrium dialysis method,Other,21474681.0,
395,1220556,1,2,,103412696,4659569,Unspecified,,,,,Fraction unbound in CD-1 mouse brain homogenates at 1 uM after 6 hrs by equilibrium dialysis method,Other,21474681.0,
396,1220557,1,2,,103412696,4659569,Unspecified,,,,,Fraction unbound in Hartley guinea pig brain homogenates at 1 uM after 6 hrs by equilibrium dialysis method,Other,21474681.0,
397,1220558,1,2,,103412696,4659569,Unspecified,,,,,Fraction unbound in Beagle dog brain homogenates at 1 uM after 6 hrs by equilibrium dialysis method,Other,21474681.0,
398,1220559,1,2,,103412696,4659569,Unspecified,,,,,Fraction unbound in cynomolgus monkey brain homogenates at 1 uM after 6 hrs by equilibrium dialysis method,Other,21474681.0,
399,1220560,1,1,,103412696,4659569,Unspecified,,,,,Fraction unbound in human occipital cortex at 1 uM after 6 hrs by equilibrium dialysis method,Other,21474681.0,
400,1224824,1,1,,50126317,4659569,Inactive,,,14.818,Potency,High-throughput drug toxicity screening in the BPDCN cell line Gen2.2,Confirmatory,,
401,1224825,1,1,,50126317,4659569,Inactive,,,23.485,Potency,High-throughput drug toxicity screening in the BPDCN cell line Cal-1,Confirmatory,,
402,1224834,3,1,,144212731,4659569,Active,,,43.2771,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
403,1224834,3,1,,170465081,4659569,Inconclusive,,,33.4915,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
404,1224835,1,1,,144212731,4659569,Active,160794.0,,63.2609,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
405,1224835,1,1,,170465081,4659569,Active,160794.0,,34.6713,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
406,1224836,1,1,,144212731,4659569,Active,,,43.2771,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
407,1224836,1,1,,170465081,4659569,Inconclusive,,,33.4915,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
408,1224837,1,1,,144212731,4659569,Inconclusive,,,61.1306,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
409,1224837,1,1,,170465081,4659569,Inconclusive,,,33.4915,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
410,1224838,1,1,,144212731,4659569,Inactive,66775687.0,9970.0,30.6379,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
411,1224838,1,1,,170465081,4659569,Inactive,66775687.0,9970.0,33.4915,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
412,1224839,1,1,,144212731,4659569,Inconclusive,66775687.0,9970.0,43.2771,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
413,1224839,1,1,,170465081,4659569,Inconclusive,66775687.0,9970.0,33.4915,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
414,1224840,3,1,,144212731,4659569,Active,,,43.2771,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
415,1224840,3,1,,170465081,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
416,1224841,3,1,,144212731,4659569,Active,325495545.0,2101.0,30.6379,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
417,1224841,3,1,,170465081,4659569,Inconclusive,325495545.0,2101.0,33.4915,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
418,1224842,3,1,,144212731,4659569,Inactive,325495545.0,2101.0,30.6379,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
419,1224842,3,1,,170465081,4659569,Inactive,325495545.0,2101.0,33.4915,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
420,1224843,1,1,,144212731,4659569,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
421,1224843,1,1,,170465081,4659569,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
422,1224844,1,1,,144212731,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
423,1224844,1,1,,170465081,4659569,Inconclusive,,,23.9145,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
424,1224845,1,1,,144212731,4659569,Inconclusive,344243002.0,100757539.0,100.715,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
425,1224845,1,1,,170465081,4659569,Inconclusive,344243002.0,100757539.0,49.193999999999996,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
426,1224846,1,1,,144212731,4659569,Inactive,11995455.0,3091.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
427,1224846,1,1,,170465081,4659569,Inconclusive,11995455.0,3091.0,26.8325,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
428,1224847,1,1,,144212731,4659569,Inconclusive,,,100.715,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
429,1224847,1,1,,170465081,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
430,1224848,3,1,,144212731,4659569,Active,325495545.0,2101.0,30.6379,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
431,1224848,3,1,,170465081,4659569,Active,325495545.0,2101.0,26.6032,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
432,1224849,3,1,,144212731,4659569,Inactive,325495545.0,2101.0,27.305999999999997,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
433,1224849,3,1,,170465081,4659569,Inactive,325495545.0,2101.0,26.6032,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
434,1224857,2,1,,50126317,4659569,Inactive,,,23.485,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human iPSC derived neural progenitor cells (hNPCs),Confirmatory,,
435,1224857,2,1,,170465081,4659569,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human iPSC derived neural progenitor cells (hNPCs),Confirmatory,,
436,1224859,2,1,,50126317,4659569,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human astrocytoma cells,Confirmatory,,
437,1224859,2,1,,170465081,4659569,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human astrocytoma cells,Confirmatory,,
438,1224863,1,1,,176484060,4659569,Inactive,90421313.0,1080.0,,IC50,Phenotypic Assay to Identify Small Molecules that Upregulate Production of hCFTR in HeLa Cells,Confirmatory,,
439,1224867,1,1,,144212731,4659569,Inconclusive,,,48.9662,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
440,1224867,1,1,,170465081,4659569,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
441,1224868,1,1,,144212731,4659569,Inconclusive,,,48.9662,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
442,1224868,1,1,,170465081,4659569,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
443,1224869,1,1,,144212731,4659569,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
444,1224869,1,1,,170465081,4659569,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
445,1224870,1,1,,144212731,4659569,Inconclusive,,,54.941,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
446,1224870,1,1,,170465081,4659569,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
447,1224871,1,1,,144212731,4659569,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
448,1224871,1,1,,170465081,4659569,Inconclusive,,,10.6822,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
449,1224872,1,1,,144212731,4659569,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
450,1224872,1,1,,170465081,4659569,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
451,1224873,1,1,,144212731,4659569,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
452,1224873,1,1,,170465081,4659569,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
453,1224874,1,1,,144212731,4659569,Active,,,48.9662,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
454,1224874,1,1,,170465081,4659569,Inconclusive,,,26.8325,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
455,1224875,1,1,,144212731,4659569,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
456,1224875,1,1,,170465081,4659569,Inconclusive,,,10.6822,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
457,1224876,1,1,,144212731,4659569,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
458,1224876,1,1,,170465081,4659569,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
459,1224877,1,1,,144212731,4659569,Inconclusive,,,48.9662,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
460,1224877,1,1,,170465081,4659569,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
461,1224878,1,1,,144212731,4659569,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
462,1224878,1,1,,170465081,4659569,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
463,1224879,1,1,,144212731,4659569,Active,,,48.9662,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
464,1224879,1,1,,170465081,4659569,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
465,1224880,1,1,,144212731,4659569,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
466,1224880,1,1,,170465081,4659569,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
467,1224881,1,1,,144212731,4659569,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
468,1224881,1,1,,170465081,4659569,Inconclusive,,,13.4481,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
469,1224882,1,1,,144212731,4659569,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
470,1224882,1,1,,170465081,4659569,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
471,1224883,1,1,,144212731,4659569,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
472,1224883,1,1,,170465081,4659569,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
473,1224884,1,1,,144212731,4659569,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
474,1224884,1,1,,170465081,4659569,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
475,1224885,1,1,,144212731,4659569,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
476,1224885,1,1,,170465081,4659569,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
477,1224886,1,1,,144212731,4659569,Inconclusive,,,54.941,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
478,1224886,1,1,,170465081,4659569,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
479,1224887,1,1,,144212731,4659569,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
480,1224887,1,1,,170465081,4659569,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
481,1224888,1,1,,144212731,4659569,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
482,1224888,1,1,,170465081,4659569,Inconclusive,,,10.6822,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
483,1224889,1,1,,144212731,4659569,Inconclusive,,,54.941,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
484,1224889,1,1,,170465081,4659569,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
485,1224890,1,1,,144212731,4659569,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
486,1224890,1,1,,170465081,4659569,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
487,1224892,1,1,,144212731,4659569,Inconclusive,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
488,1224892,1,1,,170465081,4659569,Inconclusive,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
489,1224893,1,1,,144212731,4659569,Inconclusive,66775687.0,9970.0,43.2771,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
490,1224893,1,1,,170465081,4659569,Inconclusive,66775687.0,9970.0,33.4915,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
491,1224894,1,1,,144212731,4659569,Inactive,11995455.0,3091.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
492,1224894,1,1,,170465081,4659569,Inactive,11995455.0,3091.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
493,1224895,1,1,,144212731,4659569,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
494,1224895,1,1,,170465081,4659569,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
495,1224896,1,1,,144212731,4659569,Active,344243002.0,100757539.0,68.6164,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
496,1224896,1,1,,170465081,4659569,Active,344243002.0,100757539.0,55.1965,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
497,1224905,2,1,,92308890,4659569,Inactive,120997.0,25643.0,,,High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i G protein subunits,Screening,,
498,1224905,2,1,,92308890,4659569,Inactive,74356043.0,55704.0,,,High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i G protein subunits,Screening,,
499,1224923,1,1,,103412696,4659569,Active,,,,,Summary of drugs withdrawn.,Other,,
500,1259241,1,1,,144212731,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
501,1259241,1,1,,170465081,4659569,Inconclusive,,,26.6032,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
502,1259242,1,1,,144212731,4659569,Active,,,54.4827,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
503,1259242,1,1,,170465081,4659569,Inconclusive,,,26.6032,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
504,1259243,1,1,,144212731,4659569,Active,124375976.0,367.0,30.6379,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
505,1259243,1,1,,170465081,4659569,Active,124375976.0,367.0,29.8493,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
506,1259244,1,1,,144212731,4659569,Active,348019627.0,2099.0,38.5708,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
507,1259244,1,1,,170465081,4659569,Inconclusive,348019627.0,2099.0,33.4915,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
508,1259247,1,1,,144212731,4659569,Inconclusive,124375976.0,367.0,34.3762,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
509,1259247,1,1,,170465081,4659569,Inconclusive,124375976.0,367.0,29.8493,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
510,1259248,1,1,,144212731,4659569,Active,348019627.0,2099.0,28.3743,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
511,1259248,1,1,,170465081,4659569,Inconclusive,348019627.0,2099.0,18.8336,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
512,1259252,1,1,,50126317,4659569,Inconclusive,169655958.0,,37.2212,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (RDES),Confirmatory,,
513,1259253,1,1,,50126317,4659569,Inconclusive,169655958.0,,37.2212,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (TC71),Confirmatory,,
514,1259255,1,1,,50126317,4659569,Inconclusive,169655958.0,,33.1734,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (EW8),Confirmatory,,
515,1259256,1,1,,50126317,4659569,Inconclusive,169655958.0,,37.2212,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (TC32),Confirmatory,,
516,1259310,1,1,,321949321,4659569,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
517,1259344,1,1,,144206516,4659569,Inactive,,,,Potency,qHTS assay to identify small molecule phospholipidosis (PLD) inducers,Confirmatory,,
518,1259364,1,1,,144212731,4659569,Inactive,1013403374.0,9734.0,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
519,1259364,1,1,,170465081,4659569,Inactive,1013403374.0,9734.0,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
520,1259365,1,1,,144212731,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
521,1259365,1,1,,170465081,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
522,1259366,1,1,,144212731,4659569,Inconclusive,,,76.9588,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
523,1259366,1,1,,170465081,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
524,1259367,1,1,,144212731,4659569,Active,,,54.4827,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
525,1259367,1,1,,170465081,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
526,1259368,1,1,,144212731,4659569,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
527,1259368,1,1,,170465081,4659569,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
528,1259369,1,1,,144212731,4659569,Active,109731339.0,2737.0,24.3365,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
529,1259369,1,1,,170465081,4659569,Inconclusive,109731339.0,2737.0,33.4915,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
530,1259377,1,1,,144212731,4659569,Inconclusive,54288833.0,2100.0,8.6349,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
531,1259377,1,1,,170465081,4659569,Inconclusive,54288833.0,2100.0,9.4392,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
532,1259378,1,1,,144212731,4659569,Inconclusive,54288833.0,2100.0,27.305999999999997,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
533,1259378,1,1,,170465081,4659569,Inconclusive,54288833.0,2100.0,11.8832,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
534,1259379,1,1,,144212731,4659569,Active,,,54.4827,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
535,1259379,1,1,,170465081,4659569,Active,,,29.8493,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
536,1259380,1,1,,144212731,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
537,1259380,1,1,,170465081,4659569,Inconclusive,,,8.4127,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
538,1259381,1,1,,144212731,4659569,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
539,1259381,1,1,,170465081,4659569,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
540,1259382,1,1,,144212731,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
541,1259382,1,1,,170465081,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
542,1259383,1,1,,144212731,4659569,Inactive,348019627.0,2099.0,68.5896,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
543,1259383,1,1,,170465081,4659569,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
544,1259384,1,1,,144212731,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
545,1259384,1,1,,170465081,4659569,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
546,1259385,1,1,,144212731,4659569,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
547,1259385,1,1,,170465081,4659569,Inconclusive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
548,1259386,1,1,,144212731,4659569,Active,,,27.305999999999997,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
549,1259386,1,1,,170465081,4659569,Active,,,29.8493,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
550,1259387,1,1,,144212731,4659569,Inactive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
551,1259387,1,1,,170465081,4659569,Inactive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
552,1259388,1,1,,144212731,4659569,Inactive,1013403374.0,9734.0,,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
553,1259388,1,1,,170465081,4659569,Inactive,1013403374.0,9734.0,,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
554,1259390,1,1,,144212731,4659569,Inactive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
555,1259390,1,1,,170465081,4659569,Inactive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
556,1259391,1,1,,144212731,4659569,Inactive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
557,1259391,1,1,,170465081,4659569,Inactive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
558,1259392,1,1,,144212731,4659569,Inconclusive,109731339.0,2737.0,27.305999999999997,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
559,1259392,1,1,,170465081,4659569,Inconclusive,109731339.0,2737.0,33.4915,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
560,1259393,1,1,,144212731,4659569,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
561,1259393,1,1,,170465081,4659569,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
562,1259394,1,1,,144212731,4659569,Inactive,54288833.0,2100.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
563,1259394,1,1,,170465081,4659569,Inconclusive,54288833.0,2100.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
564,1259395,1,1,,144212731,4659569,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
565,1259395,1,1,,170465081,4659569,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
566,1259396,1,1,,144212731,4659569,Active,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
567,1259396,1,1,,170465081,4659569,Inconclusive,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
568,1259400,1,1,,170465081,4659569,Inactive,166209887.0,59350.0,,,qHTS Assay for Antagonists of the Relaxin Receptor RXFP1,Screening,,
569,1259401,1,1,,144212731,4659569,Inconclusive,325495545.0,2101.0,34.3762,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
570,1259401,1,1,,170465081,4659569,Inconclusive,325495545.0,2101.0,29.8493,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
571,1259402,1,1,,144212731,4659569,Inconclusive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
572,1259402,1,1,,170465081,4659569,Inconclusive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
573,1259403,1,1,,144212731,4659569,Inconclusive,325495545.0,2101.0,37.1186,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
574,1259403,1,1,,170465081,4659569,Inconclusive,325495545.0,2101.0,26.6032,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
575,1259404,1,1,,144212731,4659569,Inconclusive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
576,1259404,1,1,,170465081,4659569,Inconclusive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
577,1259407,1,1,,363905854,4659569,Inactive,,,,,CCRIS mutagenicity studies,Other,,
578,1259416,1,2,,340087873,4659569,Active,56786138.0,3458.0,,,Toxoplasma gondii inhibition HTS in the presence of IFN-y,Screening,,
579,1259416,1,2,,340087874,4659569,Inactive,56786138.0,3458.0,,,Toxoplasma gondii inhibition HTS in the presence of IFN-y,Screening,,
580,1259421,1,1,,340087873,4659569,Active,56786138.0,3458.0,,,Toxoplasma gondii HTS in the absence of IFN-y,Screening,,
581,1259421,1,1,,340087874,4659569,Inactive,56786138.0,3458.0,,,Toxoplasma gondii HTS in the absence of IFN-y,Screening,,
